Biocon Biologics
Sowmya Koneri currently serves as Associate Director of Commercial Sales and Strategy at Biocon Biologics, having joined the company in May 2020, after a successful tenure at Quotient Limited where roles included Senior Manager for Commercial and Quality Control Manager with extensive responsibilities in quality assurance and compliance. Prior experience at Valneva included positions such as QC Lab Head for Analytical functions and Senior QC Analyst, focusing on vaccine manufacturing and analytical assay development. Educational qualifications include an Executive General Management program from the Indian Institute of Management Bangalore, a Master of Science in Biotechnology from Abertay University, and a Bachelor of Science in Biotechnology from St. Aloysius University.
This person is not in any teams
This person is not in any offices
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics